Philip Borel

Moulton puts £12m into drugs clinic(2)

UK private equity contrarian Jon Moulton has personally funded a purpose-built private drug addiction treatment centre in Kent.

BVCA says it won’t split(4)

The battered UK trade organisation says it needs “sharper focus” but intends to remain a single organisation representing VCs, mid-market groups and big LBO funds under one roof.

BVCA says it won’t split(3)

The battered UK trade organisation says it needs “sharper focus” but intends to remain a single organisation representing VCs, mid-market groups and big LBO funds under one roof.

BVCA says it won’t split(2)

The battered UK trade organisation says it needs “sharper focus” but intends to remain a single organisation representing VCs, mid-market groups and big LBO funds under one roof.

Argos Soditic adds to buy-in tally(4)

The European mid-market firm has backed a team of managers to acquire a fine chemicals company in France.

German politician demands partial “locust” ban(4)

Peter Struck, head of the SPD faction in the German parliament, is calling for rules to limit private equity’s ability to take controlling stakes in some German companies.

Argos Soditic adds to buy-in tally(3)

The European mid-market firm has backed a team of managers to acquire a fine chemicals company in France.

A law with few friends(4)

Germany’s coalition government is working on a law for private equity. A number of drafts have been published, but no one seems satisfied, writes editorial director Philip Borel.

Argos Soditic adds to buy-in tally(2)

The European mid-market firm has backed a team of managers to acquire a fine chemicals company in France.

A law with few friends(3)

Germany’s coalition government is working on a law for private equity. A number of drafts have been published, but no one seems satisfied, writes editorial director Philip Borel.